APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isosorbide Mononitrate Sustained-release Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Isosorbide Mononitrate Sustained-release Tablet Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchIsosorbide Mononitrate Sustained-release Tablet Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Isosorbide Mononitrate Sustained-release Tablet Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Isosorbide Mononitrate Sustained-release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isosorbide Mononitrate Sustained-release Tablet Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Isosorbide Mononitrate Sustained-release Tablet Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Isosorbide Mononitrate Sustained-release Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isosorbide Mononitrate Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Isosorbide Mononitrate Sustained-release Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Isosorbide Mononitrate Sustained-release Tablet market include Lotus Pharmaceuticals, Mayo Clinic, Recipeharm, Hefei Cosource Pharmacetical, Keyuan Pharmaceutical, Lepu Pharmaceuticals and Lukang Jituan Saite Yaoye, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Isosorbide Mononitrate Sustained-release Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isosorbide Mononitrate Sustained-release Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isosorbide Mononitrate Sustained-release Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isosorbide Mononitrate Sustained-release Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Isosorbide Mononitrate Sustained-release Tablet Segment by Company

Lotus Pharmaceuticals

Mayo Clinic

Recipeharm

Hefei Cosource Pharmacetical

Keyuan Pharmaceutical

Lepu Pharmaceuticals

Lukang Jituan Saite Yaoye

Isosorbide Mononitrate Sustained-release Tablet Segment by Type

40mg

50mg

Other

Isosorbide Mononitrate Sustained-release Tablet Segment by Application

Hospital

Clinic

Other

Isosorbide Mononitrate Sustained-release Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Isosorbide Mononitrate Sustained-release Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Isosorbide Mononitrate Sustained-release Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isosorbide Mononitrate Sustained-release Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Isosorbide Mononitrate Sustained-release Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isosorbide Mononitrate Sustained-release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isosorbide Mononitrate Sustained-release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isosorbide Mononitrate Sustained-release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isosorbide Mononitrate Sustained-release Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isosorbide Mononitrate Sustained-release Tablet industry.

Chapter 3: Detailed analysis of Isosorbide Mononitrate Sustained-release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Isosorbide Mononitrate Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Isosorbide Mononitrate Sustained-release Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isosorbide Mononitrate Sustained-release Tablet Industry Trends Table 2. Isosorbide Mononitrate Sustained-release Tablet Industry Drivers Table 3. Isosorbide Mononitrate Sustained-release Tablet Industry Opportunities and Challenges Table 4. Isosorbide Mononitrate Sustained-release Tablet Industry Restraints Table 5. Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isosorbide Mononitrate Sustained-release Tablet Revenue Share by Company (2021-2026) Table 7. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Company (k units) & (2021-2026) Table 8. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Isosorbide Mononitrate Sustained-release Tablet Average Price (US$/unit) of Company (2021-2026) Table 10. Global Isosorbide Mononitrate Sustained-release Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Isosorbide Mononitrate Sustained-release Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Isosorbide Mononitrate Sustained-release Tablet Company, Product Type & Application Table 13. Global Isosorbide Mononitrate Sustained-release Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Isosorbide Mononitrate Sustained-release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg Table 18. Significant Companies of 50mg Table 19. Significant Companies of Other Table 20. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2021-2026) & (k units) Table 22. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2027-2032) & (k units) Table 23. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Type (2021-2026) Table 24. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Type (2027-2032) Table 25. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type (2021-2026) Table 29. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2021-2026) & (k units) Table 35. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2027-2032) & (k units) Table 36. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Application (2021-2026) Table 37. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Application (2027-2032) Table 38. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application (2021-2026) Table 42. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application (2027-2032) Table 43. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region (2021-2026) & (k units) Table 45. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Region (2021-2026) Table 46. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region (2027-2032) & (k units) Table 47. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Region (2027-2032) Table 48. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Region (2021-2026) Table 51. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Region (2027-2032) Table 53. Global Isosorbide Mononitrate Sustained-release Tablet Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Isosorbide Mononitrate Sustained-release Tablet Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 58. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Country (2021-2026) Table 59. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 60. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Country (2027-2032) Table 61. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Market Share by Country (2021-2026) Table 63. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Market Share by Country (2027-2032) Table 65. Lotus Pharmaceuticals Company Information Table 66. Lotus Pharmaceuticals Business Overview Table 67. Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 69. Lotus Pharmaceuticals Recent Development Table 70. Mayo Clinic Company Information Table 71. Mayo Clinic Business Overview Table 72. Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 74. Mayo Clinic Recent Development Table 75. Recipeharm Company Information Table 76. Recipeharm Business Overview Table 77. Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 79. Recipeharm Recent Development Table 80. Hefei Cosource Pharmacetical Company Information Table 81. Hefei Cosource Pharmacetical Business Overview Table 82. Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 84. Hefei Cosource Pharmacetical Recent Development Table 85. Keyuan Pharmaceutical Company Information Table 86. Keyuan Pharmaceutical Business Overview Table 87. Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 89. Keyuan Pharmaceutical Recent Development Table 90. Lepu Pharmaceuticals Company Information Table 91. Lepu Pharmaceuticals Business Overview Table 92. Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 94. Lepu Pharmaceuticals Recent Development Table 95. Lukang Jituan Saite Yaoye Company Information Table 96. Lukang Jituan Saite Yaoye Business Overview Table 97. Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product Portfolio Table 99. Lukang Jituan Saite Yaoye Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Isosorbide Mononitrate Sustained-release Tablet Distributors List Table 103. Isosorbide Mononitrate Sustained-release Tablet Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Isosorbide Mononitrate Sustained-release Tablet Product Image Figure 2. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Isosorbide Mononitrate Sustained-release Tablet Sales (2021-2032) & (k units) Figure 5. Global Isosorbide Mononitrate Sustained-release Tablet Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Isosorbide Mononitrate Sustained-release Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg Image Figure 10. 50mg Image Figure 11. Other Image Figure 12. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Type (2021-2032) Figure 15. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Application (2021-2032) Figure 24. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application (2021-2032) Figure 27. Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Isosorbide Mononitrate Sustained-release Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032) & (US$ Million) Figure 32. North America Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032) & (US$ Million) Figure 38. South America Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Isosorbide Mononitrate Sustained-release Tablet Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Isosorbide Mononitrate Sustained-release Tablet Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 50mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Lotus Pharmaceuticals
  • Mayo Clinic
  • Recipeharm
  • Hefei Cosource Pharmacetical
  • Keyuan Pharmaceutical
  • Lepu Pharmaceuticals
  • Lukang Jituan Saite Yaoye

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Isosorbide Mononitrate Sustained-release Tablet Market Dynamics
  1. 2.1 Isosorbide Mononitrate Sustained-release Tablet Industry Trends
  2. 2.2 Isosorbide Mononitrate Sustained-release Tablet Industry Drivers
  3. 2.3 Isosorbide Mononitrate Sustained-release Tablet Industry Opportunities and Challenges
  4. 2.4 Isosorbide Mononitrate Sustained-release Tablet Industry Restraints
3 Isosorbide Mononitrate Sustained-release Tablet Market by Company
  1. 3.1 Global Isosorbide Mononitrate Sustained-release Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Isosorbide Mononitrate Sustained-release Tablet Company Ranking (2024-2026)
  6. 3.6 Global Isosorbide Mononitrate Sustained-release Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Isosorbide Mononitrate Sustained-release Tablet Company Product Type and Application
  8. 3.8 Global Isosorbide Mononitrate Sustained-release Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Isosorbide Mononitrate Sustained-release Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Isosorbide Mononitrate Sustained-release Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Isosorbide Mononitrate Sustained-release Tablet Market by Type
  1. 4.1 Isosorbide Mononitrate Sustained-release Tablet Type Introduction
  2. 4.1.1 40mg
  3. 4.1.2 50mg
  4. 4.1.3 Other
  5. 4.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type
  6. 4.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type
  10. 4.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Type (2021-2032)
  12. 4.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type (2021-2032)
5 Isosorbide Mononitrate Sustained-release Tablet Market by Application
  1. 5.1 Isosorbide Mononitrate Sustained-release Tablet Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application
  6. 5.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application
  10. 5.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application (2021-2032)
6 Isosorbide Mononitrate Sustained-release Tablet Regional Sales and Value Analysis
  1. 6.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Region (2027-2032)
  5. 6.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Isosorbide Mononitrate Sustained-release Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Country, 2025 VS 2032
7 Isosorbide Mononitrate Sustained-release Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales by Country (2027-2032)
  6. 7.4 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Isosorbide Mononitrate Sustained-release Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Isosorbide Mononitrate Sustained-release Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lotus Pharmaceuticals
  2. 8.1.1 Lotus Pharmaceuticals Company Information
  3. 8.1.2 Lotus Pharmaceuticals Business Overview
  4. 8.1.3 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  6. 8.1.5 Lotus Pharmaceuticals Recent Developments
  7. 8.2 Mayo Clinic
  8. 8.2.1 Mayo Clinic Company Information
  9. 8.2.2 Mayo Clinic Business Overview
  10. 8.2.3 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  12. 8.2.5 Mayo Clinic Recent Developments
  13. 8.3 Recipeharm
  14. 8.3.1 Recipeharm Company Information
  15. 8.3.2 Recipeharm Business Overview
  16. 8.3.3 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  18. 8.3.5 Recipeharm Recent Developments
  19. 8.4 Hefei Cosource Pharmacetical
  20. 8.4.1 Hefei Cosource Pharmacetical Company Information
  21. 8.4.2 Hefei Cosource Pharmacetical Business Overview
  22. 8.4.3 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  24. 8.4.5 Hefei Cosource Pharmacetical Recent Developments
  25. 8.5 Keyuan Pharmaceutical
  26. 8.5.1 Keyuan Pharmaceutical Company Information
  27. 8.5.2 Keyuan Pharmaceutical Business Overview
  28. 8.5.3 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  30. 8.5.5 Keyuan Pharmaceutical Recent Developments
  31. 8.6 Lepu Pharmaceuticals
  32. 8.6.1 Lepu Pharmaceuticals Company Information
  33. 8.6.2 Lepu Pharmaceuticals Business Overview
  34. 8.6.3 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  36. 8.6.5 Lepu Pharmaceuticals Recent Developments
  37. 8.7 Lukang Jituan Saite Yaoye
  38. 8.7.1 Lukang Jituan Saite Yaoye Company Information
  39. 8.7.2 Lukang Jituan Saite Yaoye Business Overview
  40. 8.7.3 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product Portfolio
  42. 8.7.5 Lukang Jituan Saite Yaoye Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isosorbide Mononitrate Sustained-release Tablet Value Chain Analysis
  2. 9.1.1 Isosorbide Mononitrate Sustained-release Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isosorbide Mononitrate Sustained-release Tablet Sales Mode & Process
  6. 9.2 Isosorbide Mononitrate Sustained-release Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isosorbide Mononitrate Sustained-release Tablet Distributors
  9. 9.2.3 Isosorbide Mononitrate Sustained-release Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst